Presented at the Meeting of the Western Section of the American Laryngological, Rhinological and Otological Society, Inc., Scottsdale, Arizona, January 12, 1997.
Hypopharyngeal Cancer Patient Care Evaluation†
Version of Record online: 1 JUN 2009
Copyright © 1997 The Triological Society
Volume 107, Issue 8, pages 1005–1017, August 1997
How to Cite
Hoffman, H. T., Karnell, L. H., Shah, J. P., Ariyan, S., Brown, G. S., Fee, W. E., Glass, A. G., Goepfert, H., Ossoff, R. H. and Fremgen, A. M. (1997), Hypopharyngeal Cancer Patient Care Evaluation. The Laryngoscope, 107: 1005–1017. doi: 10.1097/00005537-199708000-00001
This study received funding from the American College of Surgeons and the American Cancer Society.
- Issue online: 1 JUN 2009
- Version of Record online: 1 JUN 2009
A survey was conducted to identify demographics and standards of care for treatment of hypopharyngeal squamous cell carcinoma in the United States. Data were accrued from voluntary submission of cancer registry and medical chart information from 769 hospitals representing 2939 cases diagnosed from 1980 to 1985 and 1990 to 1992. Clinical findings, diagnostic procedures employed, treatment practices, and outcome are presented. Overall, 5-year disease-specific survival was 33.4%, which segregated to 63.1% (stage I), 57.5%(stage II), 41.8% (stage III), and 22% (stage IV). Survival was best for patients treated with surgery only (50.4%), similar with combined surgery and irradiation (48%), and worse with irradiation only (25.8%). This analysis provides a standard to which current treatment practice and future clinical trials may be compared.